Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Références<br />
214. Berenguer J, Bellon JM, Miral<strong>le</strong>s P, Alvarez E, Sanchez-Conde M, Cosin J, et al. Identification of liver<br />
fibrosis in HIV/HCV-coinfected patients using a simp<strong>le</strong> predictive model based on routine laboratory data. J<br />
Viral Hepat. 2007 Dec;14(12):859-69.<br />
215. Cacoub P, Carrat F, Bedossa P, Lambert J, Penaranda G, Perronne C, et al. Comparison of non-invasive liver<br />
fibrosis biomarkers in HIV/HCV co-infected patients: the fibrovic study--ANRS HC02. J Hepatol. 2008<br />
May;48(5):765-73.<br />
216. Myers RP, Benhamou Y, Imbert-Bismut F, Thibault V, Bochet M, Charlotte F, et al. Serum biochemical<br />
markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients. Aids. 2003 Mar<br />
28;17(5):721-5.<br />
217. Nunes D, F<strong>le</strong>ming C, Offner G, O'Brien M, Tumilty S, Fix O, et al. HIV infection does not affect the<br />
performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease. J<br />
Acquir Immune Defic Syndr. 2005;40:538-44.<br />
218. Kel<strong>le</strong>herb TB, Mehtaa SH, Bhaskarb R, Sulkowskic M, Astemborskic J, Thomasa DL, et al. Prediction of<br />
hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: The SHASTA index. Journal<br />
of Hepatology. 2005;43:78-84.<br />
219. Resino S, Micheloud D, Miral<strong>le</strong>s P, Bellon JM, Vargas A, Catalan P, et al. Diagnosis of advanced fibrosis in<br />
HIV and hepatitis C virus-coinfected patients via a new noninvasive index: the HGM-3 index. HIV Med.<br />
2009 Aug 3.<br />
220. Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simp<strong>le</strong><br />
noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology.<br />
2006;43:1317-25.<br />
221. Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, et al. Noninvasive assessment of liver<br />
fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology. 2005 Jan;41(1):48-54.<br />
222. Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, et al. Prospective comparison of<br />
transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.<br />
Gastroenterology. 2005;128:343-50.<br />
223. Foucher J, Chanteloup E, Vergniol J, Castera L, Le Bail B, Adhoute X, et al. Diagnosis of cirrhosis by<br />
transient elastography (FibroScan): a prospective study. Gut. 2006 Mar;55(3):403-8.<br />
224. Vergara S, Macias J, Rivero A, Gutierrez-Va<strong>le</strong>ncia A, Gonza<strong>le</strong>z-Serrano M, Merino D, et al. The use of<br />
transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection. Clin<br />
Infect Dis. 2007 Oct 15;45(8):969-74.<br />
225. Macias J, Recio E, Vispo E, Rivero A, Lopez-Cortes LF, Rios MJ, et al. Application of transient elastometry<br />
to differentiate mild from moderate to severe liver fibrosis in HIV/HCV co-infected patients. J Hepatol. 2008<br />
Dec;49(6):916-22.<br />
226. Kirk GD, Astemborski J, Mehta SH, Spo<strong>le</strong>r C, Fisher C, Al<strong>le</strong>n D, et al. Assessment of liver fibrosis by<br />
transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection. Clin<br />
Infect Dis. 2009 Apr 1;48(7):963-72.<br />
227. Mehta SH, Lau B, Afdhal NH, Thomas DL. Exceeding the limits of liver histology markers. J Hepatol. 2009<br />
Jan;50(1):36-41.<br />
228. Leroy V, Hil<strong>le</strong>ret MN, Sturm N, Trocme C, Renversez JC, Faure P, et al. Prospective comparison of six noninvasive<br />
scores for the diagnosis of liver fibrosis in chronic hepatitis C. J Hepatol. 2007;46:775-82.<br />
229. Halfon P, Bourliere M, Deydier R, Botta-Fridlund D, Renou C, Tran A, et al. Independent prospective<br />
multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and<br />
activity in patients with chronic hepatitis C: the fibropaca study. Am J Gastroenterol. 2006;101:547-55.<br />
230. Shaheen AA, Wan AF, Myers RP. FibroTest and FibroScan for the Prediction of Hepatitis C-Related<br />
Fibrosis: A Systematic Review of Diagnostic Test Accuracy. Am J Gastroenterol. 2007 Nov;102(11):2589-<br />
600.<br />
231. Halfon P, Bourliere M, Penaranda G, Cacoub P. [Serum markers of non-invasive fibrosis in chronic hepatitis<br />
C virus infection]. Rev Med Interne. 2006 Oct;27(10):751-61.<br />
232. Idobe Y, Murawaki Y, Ikuta Y, Koda M, Kawasaki H. Post-prandial serum hyaluronan concentration in<br />
patients with chronic liver disease. Intern Med. 1998 Jul;37(7):568-75.<br />
233. Halfon P, Imbert-Bismut F, Messous D, Antoniotti G, Benchetrit D, Cart-Lamy P, et al. A prospective<br />
assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity<br />
(ActiTest) in patients with chronic liver disease. Comp Hepatol. 2002 Dec 30;1(1):3.<br />
234. Bourliere M, Penaranda G, Ouzan D, Renou C, Botta-Fridlund D, Tran A, et al. Optimized stepwise<br />
combination algorithms of non-invasive liver fibrosis scores including Hepascore in hepatitis C virus patients.<br />
Aliment Pharmacol Ther. 2008 Aug 15;28(4):458-67.<br />
235. Sebastiani G, Halfon P, Castera L, Pol S, Thomas DL, Mangia A, et al. SAFE biopsy: a validated method for<br />
large-sca<strong>le</strong> staging of liver fibrosis in chronic hepatitis C. Hepatology. 2009 Jun;49(6):1821-7.<br />
236. Boursier J, Vergniol J, Sawadogo A, Dakka T, Michalak S, Gallois Y, et al. The combination of a blood test<br />
and Fibroscan improves the non-invasive diagnosis of liver fibrosis. Liver Int. 2009 Nov;29(10):1507-15.<br />
186
Change language